Maximilian Stahl (@maxstahlmd) 's Twitter Profile
Maximilian Stahl

@maxstahlmd

leukemia faculty @DanaFarber @harvardmed | fellowship @sloan_kettering | residency @YaleIMed @YaleIM_Chiefs | Med Hochschule Hannover

ID: 1372629451218038792

calendar_today18-03-2021 19:22:25

104 Tweet

598 Followers

255 Following

Anand Patel (@anand_88_patel) 's Twitter Profile Photo

Enjoyed reading this analysis of HMA-VEN & IC in pt ≥60yo w/ newly-dx IDHm AML led by Shai Shimony Maximilian Stahl Rory M. Shallis, MD et al #leusm -151 pt (81 IC 70 HMA-VEN) -cCR rate 67% for both groups -2y OS 45% for cohort (51% for IC, 35% for HMA-VEN p=0.14) onlinelibrary.wiley.com/doi/full/10.10…

Enjoyed reading this analysis of HMA-VEN &amp; IC in pt ≥60yo w/ newly-dx IDHm AML led by <a href="/ShaiShimony/">Shai Shimony</a> <a href="/MaxStahlMD/">Maximilian Stahl</a> <a href="/Dr_RoryShallis/">Rory M. Shallis, MD</a> et al #leusm
-151 pt (81 IC 70 HMA-VEN)
-cCR rate 67% for both groups
-2y OS 45% for cohort (51% for IC, 35% for HMA-VEN p=0.14)
onlinelibrary.wiley.com/doi/full/10.10…
Maximilian Stahl (@maxstahlmd) 's Twitter Profile Photo

Mark your calendars for PER’s 8th Annual Live Medical Crossfire®: Hematologic Malignancies on July 20th! Register for FREE using my last name as a discount code and don’t miss this #CME opportunity! bit.ly/43gPxpg #gotoPER #HemeOnc Barbara Pro Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Amer Zeidan MBBS,MHS ‏عامر زيدان

Talha Badar (@talhabadarmd) 's Twitter Profile Photo

SH vs MH TP53 mutated AML Conclusion: Unlike lower risk MDS, we did not find a significant difference in response rate or survival outcome among patients with SH vs MH TP53 MT AML, which is consistent with recent reports.

Maximilian Stahl (@maxstahlmd) 's Twitter Profile Photo

Come to our talk ASCO education session to learn all about TP53 mutations in MDS and AML. Joined presentation with Valeria Santini and David Sallman!

Come to our talk <a href="/ASCO/">ASCO</a> education session to learn all about TP53 mutations in MDS and AML. Joined presentation with Valeria Santini and David Sallman!
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

Check out our recent session featuring experts Amer Zeidan MBBS,MHS ‏عامر زيدان, Sophie Park, Yasmin Abaza, and Maximilian Stahl, who discuss the practical management of anemia in LR-MDS. Watch here: 👉ow.ly/W4cn50Sb3FF 👈 #MDSsm #HemOnc #Anemia #Hematology

Check out our recent session featuring experts <a href="/Dr_AmerZeidan/">Amer Zeidan MBBS,MHS ‏عامر زيدان</a>, Sophie Park, <a href="/yasminabaza1/">Yasmin Abaza</a>, and <a href="/MaxStahlMD/">Maximilian Stahl</a>, who discuss the practical management of anemia in LR-MDS. 

Watch here: 👉ow.ly/W4cn50Sb3FF 👈

#MDSsm #HemOnc #Anemia #Hematology
Maximilian Stahl (@maxstahlmd) 's Twitter Profile Photo

Don’t miss PER’s annual summer #hematology meeting! Plan your trip to the big apple, earn CME and networks with experts! Sign up today for FREE using my last name as a discount code! bit.ly/43gPxpg #gotoPER #MXH #HemeOnc Barbara Pro Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Amer Zeidan MBBS,MHS ‏عامر زيدان 📷

VJHemOnc (@vjhemonc) 's Twitter Profile Photo

#iwAL2024 | Maximilian Stahl of Dana-Farber gives a lovely presentation on optimal maintenance strategies in patients with AML not going to ASCT. #AMLsm #LeuSM #BMTsm #HemOnc

#iwAL2024 | <a href="/MaxStahlMD/">Maximilian Stahl</a> of <a href="/DanaFarber/">Dana-Farber</a> gives a lovely presentation on optimal maintenance strategies in patients with AML not going to ASCT.

#AMLsm #LeuSM #BMTsm #HemOnc
VJHemOnc (@vjhemonc) 's Twitter Profile Photo

And that's a wrap on the first session at #iwAL2024! An extremely engaging panel discussion w/ Eytan Stein, Charlie Craddock CBE, Andrew Wei, Tapan Kadia, Maximilian Stahl & Tara Lin! #AMLsm #LeuSM #HemOnc #iwAL24

And that's a wrap on the first session at #iwAL2024! An extremely engaging panel discussion w/ Eytan Stein, <a href="/charliecraddock/">Charlie Craddock CBE</a>, Andrew Wei, <a href="/TapKadia/">Tapan Kadia</a>, <a href="/MaxStahlMD/">Maximilian Stahl</a> &amp; Tara Lin!

#AMLsm #LeuSM #HemOnc #iwAL24